腺素A2B受体促进瘤进展和转移在未分化形肉瘤中的转移
Mariella Spalato Ceruso1, Jean-Philippe Guégan2, Aurelien Bourdon1
1Institut Bergonié Bordeaux France.
概括
这项研究表明,ADORA2B在未分化的多形肉瘤 (UPS) 中驱动转移. 抑制ADORA2B可能是治疗这种侵袭性软组织肉瘤的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 不差异化的多形肉瘤 (UPS) 是一种具有攻击性的软组织肉瘤,预后不佳,特别是在转移阶段.
- 目前尚不清楚UPS转移的分子机制,这阻碍了开发有效的治疗方法.
研究的目的:
- 调查不分化的多形肉瘤 (UPS) 中转移的分子驱动因素.
- 确定潜在的治疗点,以抑制UPS转移并改善患者的治疗结果.
主要方法:
- 采用多omics方法,包括空间转录组学和散装RNA测序,对配对的初级和转移性UPS瘤.
- 在UPS细胞系和体内模型中利用CRISPR-Cas9基因编辑来对已识别的途径进行功能验证.
- 进行了解体分析,以评估与转移相关的瘤免疫微环境的变化.
主要成果:
- 在转移性UPS中发现了缺氧,上皮-介质细胞转换 (EMT) 和免疫抑制途径的显著上调.
- 确定ADORA2B是关键的驱动因素,其高表达与UPS患者无病存活率降低相关.
- 功能性研究表明,ADORA2B促进瘤细胞增殖,迁移,入侵和矩阵重塑;体内,ADORA2B淘汰会减少瘤生长和转移.
结论:
- 阿多拉2B是不分化的多形肉瘤 (UPS) 中转移性进展的关键调节者.
- 在UPS中,ADORA2B是破坏转移的有希望的治疗标.
- 这些发现支持正在进行的临床试验,以向腺路径为潜在的UPS治疗.
相关概念视频
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
The Eukaryotic Promoter Region
18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
The Eukaryotic Promoter Region
4.0K
4.0K
Rous Sarcoma Virus (RSV) and Cancer
6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.4K
Receptor-mediated Endocytosis
111.0K
Overview
111.0K


